Effect of Hypnosis on Pain, Anxiety, and Quality of Life in Female Patients with Fibromyalgia: Prospective, Randomized, Controlled Study.
Seyda Efsun OzgunayMeliha Kasapoğlu AksoyKubra Nur DenizSinay OnenTugba OnurNermin KilicarslanSermin EminogluDerya KarasuPublished in: The International journal of clinical and experimental hypnosis (2023)
This prospective, randomized, controlled study aimed to investigate the effects of standardized adjuvant hypnosis on pain, depression, anxiety, aerobic exercise practices, quality of life, and disease impact score in female patients with fibromyalgia syndrome (FMS). This study included 47 female patients with FMS who had been under treatment for at least six months. The hypnosis group ( n = 24) received a total of three hypnosis sessions and was taught to patients' self-hypnosis. The patients in this group practiced self-hypnosis for six months. During this period, all patients also continued their medical treatment. The Visual Analogue Scale (VAS) was used to determine the intensity of pain. At the end of the six-month follow-up period, it was determined that the patients of FMS with hypnosis therapy had lower pain intensity, FMS symptoms, depression, and anxiety symptoms, and better well-being than those in the control group ( p < .05). Standardized hypnosis is an effective method in reducing pain, depression and anxiety symptoms and improving quality of life in patients with FMS.
Keyphrases
- end stage renal disease
- tyrosine kinase
- chronic pain
- newly diagnosed
- ejection fraction
- chronic kidney disease
- pain management
- healthcare
- neuropathic pain
- peritoneal dialysis
- prognostic factors
- open label
- depressive symptoms
- patient reported outcomes
- spinal cord injury
- mesenchymal stem cells
- bone marrow
- double blind
- phase ii